BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/9/2026 9:45:11 AM | Browse: 2 | Download: 0
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 123002
Country China
Received
2026-05-06 03:21
Peer-Review Started
2026-05-06 03:21
First Decision by Editorial Office Director
2026-05-15 09:33
Return for Revision
2026-05-15 09:33
Revised
2026-05-21 06:32
Publication Fee Transferred
2026-05-25 06:38
Second Decision by Editor
2026-06-15 02:39
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-06-15 06:25
Articles in Press
2026-06-15 06:25
Edit the Manuscript by Language Editor
Typeset the Manuscript
2026-08-20 08:01
Publish the Manuscript Online
2026-09-09 09:45
ISSN 1948-5204 (online)
Open Access This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Review
Article Title Cuproptosis in gastric cancer: Mechanisms and therapeutic opportunities
Manuscript Source Unsolicited Manuscript
All Author List Yi-Ping Fang, Shu-Ni Liu, Feng-Ping Liu, Jing-Wen Gong, Yi-Fan Zhang, Jun-Hui Lu, Jing-Wei Liu, Qing Wang and Xing Chen
ORCID
Author(s) ORCID Number
Xing Chen http://orcid.org/0000-0002-9087-4232
Funding Agency and Grant Number
Funding Agency Grant Number
Construction and Validation of a Prognostic Risk Scoring Model Related to Cuproptosis-Characteristic Genes in Gastric Cancer SYYYRC-2022002
Evaluation of the Efficacy and Safety of Different Doses of Saccharomyces boulardii Combined with Dual Regimens for the Eradication of Helicobacter pylori ITT-2025-125
Corresponding Author Xing Chen, MD, Department of Gastroenterology, The First Hospital of Shanxi Medical University, No. 56 Xinjian South Road, Taiyuan 030001, Shanxi Province, China. chen0419xing@163.com
Key Words Cuproptosis; Copper metabolism; Gastric cancer; Tumor microenvironment; Immunotherapy; Copper ionophores; Copper chelators; Nanomedicine; Biomarkers
Core Tip Cuproptosis connects copper imbalance with mitochondrial metabolic vulnerability, angiogenesis, immune regulation, and treatment resistance in gastric cancer. This review summarizes copper homeostasis, protein lipoylation, oncogenic signaling, the tumor microenvironment, and copper-modulating therapies. It highlights copper ionophores, chelators, nanomedicine, and biomarkers, including ferredoxin 1, amine oxidase copper-containing 1, integrin beta 1, and serpin family E member 1, for patient stratification and rational combination therapy while emphasizing toxicity and translational challenges.
Publish Date 2026-09-09 09:45
Citation

Fang YP, Liu SN, Liu FP, Gong JW, Zhang YF, Lu JH, Liu JW, Wang Q, Chen X. Cuproptosis in gastric cancer: Mechanisms and therapeutic opportunities. World J Gastrointest Oncol 2026; 18(9): 123002

URL https://www.wjgnet.com/1948-5204/full/v18/i9/123002.htm
DOI https://doi.org/10.4251/wjgo.123002
Full Article (PDF) WJGO-18-123002-with-cover.pdf
Manuscript File 123002_Auto_Edited_054650.docx
Answering Reviewers 123002-answering-reviewers.pdf
Audio Core Tip 123002-audio.mp3
Conflict-of-Interest Disclosure Form 123002-conflict-of-interest-statement.pdf
Copyright License Agreement 123002-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate 123002-non-native-speakers.pdf
Supplementary Material 123002-supplementary-material.pdf
Peer-review Report 123002-peer-reviews.pdf
Scientific Misconduct Check 123002-scientific-misconduct-check.png
CrossCheck Report 123002-crosscheck-report.pdf